SHENZHEN, China, March 1 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the “Company” or “Tongjitang”) , a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it plans to announce its fourth quarter and full year 2009 financial results before the market opens on Wednesday, March 31, 2010.
Tongjitang’s management team will hold a conference call on March 31 at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing/Hong Kong time) following the announcement. Listeners may access the call by dialing the following numbers:
Listeners may access the replay through April 7, 2010, by dialing the following numbers:
An audio webcast of the call will also be available through the Company’s website at http://www.tongjitang.com .
About Tongjitang Chinese Medicines Company
Tongjitang Chinese Medicines Company, through its operating subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution, Tongjitang Chain Stores, Guizhou Long-Life Pharmaceutical Company Limited, Qinghai Pulante and Anhui Jingfang, is a vertically integrated specialty pharmaceutical company focused on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China. Tongjitang’s principal executive offices are located in Shenzhen, China.
Tongjitang’s flagship product, Xianling Gubao, is the leading traditional Chinese medicine for the treatment of osteoporosis in China as measured by sales in Renminbi. In addition to Xianling Gubao, the Company manufactures and markets 36 other modernized traditional Chinese medicine products and 37 western medicines. Please visit http://www.tongjitang.com for more information.
CONTACT: ICR, Inc., Ashley M. Ammon or Christine Duan, +1-203-682-8200
(Investor Relations)
Web site: http://www.tongjitang.com/
